Kernel Group Holdings (NASDAQ:BIOT) announced in an 8-K that it has agreed to sell most of its sponsor economics and undergo a management change.
VKSS Capital is coming in to purchase 7,187,500 of the sponsor’s promote shares (94.3%) at par value $0.0001 per share, leaving the original sponsor 431,250 remaining. VKSS is also purchasing all 8,750,000 of Kernel sponsor’s private placement warrants for an aggregate purchase price of $1.
The larger piece of compensation going Kernel’s way is in the form of 2,000,000 promote shares to be distributed to members of the original sponsor pro rata. Four members of the original sponsor – CEO Mark Gross, CFO Rakesh Tondon, COO Brett Northart, and Chief Administrative Officer Mike Newbold – are also to receive a payment of $250,000 and 125,000 promote shares each as an advisor fee.
Taking their place are newly appointed Chairman and CEO Surendra Ajjarapu and CFO Howard Doss as well as four other new Board members.
Both men are recent SPAC veterans and they serve in the same roles leading Aesther Healthcare Acquisition Corp. (NASDAQ:AEHA), which is working to close a combination with Ocean Biomedical.
Ajjarapu is also a director of OceanTech Acquisition I Corp. (NASDAQ:OTEC), which terminated an earlier deal with Captura Biopharma and is now working to close its combination with Indian fintech Majic Wheels (OTC:MJWL).
The pair of executives have also collaborated in these same roles at Txrade Group (NASDAQ:MEDS) a microcap online marketplace for pharmaceuticals. This expertise would indicate that the new SPAC team will shift focus to biopharm from Kernel’s initial hunt in the supply chain technology space, but incoming Board appointees also have some EV and renewable energy experience.
They are getting behind the wheel of a SPAC vehicle that IPO’d in Februrary 2021 with 1/2 warrants in its units and no overfunding of its trust – terms that would be difficult to finagle in the current market environment. But, Kernel is also heading towards its initial transaction deadline on February 5.
So, the incoming management will likely have to get through an extension to keep the ride going, while the original management has secured some upside while dodging the extension hassle.
At the SPAC of Dawn While futures indicate the Santa rally may be retreating back to the North Pole, de-SPACs have nonetheless notched a solid week and SPACs still in other points in their processes still have plenty of business left on their plate. Three SPACs are asking shareholders for extensions today while two more...
SPACInsider 2024 Awards 2024 was clearly a rebuilding year for SPACs and the pace didn’t really gather momentum until June. But in typical SPAC fashion, once the market catches fire, it builds very, very quickly. With that being said, there are some noteworthy standouts this year that are worth highlighting. As such, this is the...
At the SPAC of Dawn (UPDATED) It was a slow start to the day after the Christmas holiday, especially because the SEC was “experiencing technical difficulties” this morning. That makes for a slow news day. Other than that, we hope everyone had a great holiday and is easing back into the work flow. Deals and...
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...